Evidence map›Paper›PMID 39629995›Full record

ArticleJournal of virology2025

Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants.

Fanglei Zuo, Yunlong Cao, Rui Sun, Qianran Wang, Luca Simonelli, Likun Du, Federico Bertoglio, Maren Schubert, Concetta Guerra, Andrea Cavalli and 8 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Fanglei ZuoDivision of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-4545-1265
Yunlong CaoBiomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China.
Rui SunDivision of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Qianran WangBiomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China.
Luca SimonelliInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Likun DuDivision of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Federico BertoglioInstitute of Biochemistry, Biotechnology and Bioinformatics, Department of Medical Biotechnology, Technische Universität Braunschweig, Braunschweig, Germany.
Maren SchubertInstitute of Biochemistry, Biotechnology and Bioinformatics, Department of Medical Biotechnology, Technische Universität Braunschweig, Braunschweig, Germany.
Concetta GuerraInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Andrea CavalliInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Michael HustInstitute of Biochemistry, Biotechnology and Bioinformatics, Department of Medical Biotechnology, Technische Universität Braunschweig, Braunschweig, Germany.
Davide F RobbianiInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Luca VaraniInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Hassan AbolhassaniDivision of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Xiaoliang Sunney XieBiomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China.
Lennart HammarströmDivision of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Harold Marcotte *Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-7168-349X
Qiang Pan-Hammarström *Division of Immunology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-1990-8804

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dimeric IgAimmune escapeneutralizing antibodiesSARS-CoV-2

Identifiers

PMID39629995
PMCPMC11784158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.